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Abstract
 The Makerere University/Uganda Virus Research InstituteBackground:
(UVRI) Centre of Excellence for Infection & Immunity Research and
Training (MUII) is a collaborative programme supporting excellence in
Infection and Immunity (I&I) research in Uganda. Set up in 2008, MUII aims
to produce internationally competitive Ugandan and East African I&I
research leaders, and develop human and infrastructural resources to
support research and training excellence. We undertook an internal
evaluation of MUII’s achievements, challenges and lessons learned
between August 2008 and December 2019, to inform programmes seeking
to build Africa’s health research expertise.
Quantitative data were abstracted from programme annualMethods: 
reports. Qualitative data were obtained in March and April 2019: a
cross-sectional evaluation was undertaken among a purposefully selected
representative sample of 27 trainees and two programme staff. Qualitative
data was analysed according to pre-determined themes of achievements,
challenges, lessons learned and recommendations for improvement.
 By December 2019, MUII had supported 68 fellowships atResults:
master’s-level and above (50% female: 23 Masters, 27 PhD, 15
post-doctoral, three group-leader fellows) and over 1,000 internships.
Fellows reported career advancement, mentorship by experts, and
improved research skills and outputs. Fellows have published over 300
papers, secured grants worth over £20m, established over 40 international
collaborations, and taken on research and academic leadership positions in
the country. Key lessons for success include the following: efficient
administration provides an enabling environment; institutions need
supportive policies for procurement, including provisions for purchases of
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supportive policies for procurement, including provisions for purchases of
specific biological research reagents from international manufacturers;
strong international, multi-disciplinary collaboration provides a critical mass
of expertise to mentor researchers in development; and mentorship
catalyses young scientists to progress from graduate trainees to productive
academic researchers, relevant to society’s most pressing health
challenges.
Sustainable academic productivity can be achieved throughConclusions: 
efficient operational support, global collaboration and mentorship to provide
solutions to Africa’s health challenges.
Keywords
Academic careers, capacity building for research, Infection and Immunity,
Immunology, bioinformatics, mentorship, collaboration, partnership,
sub-Saharan Africa
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Introduction
From its inception in 2008 as a training programme, and 
transition in 2016 to a Centre of Excellence, the Makerere 
University/Uganda Virus Research Institute (UVRI) Centre of 
Excellence for Infection & Immunity Research and Training 
(MUII) has earned a reputation for building Ugandan capacity 
in infection and immunity (I&I) research. MUII, a partnership 
between Uganda’s leading health research institute (UVRI) and 
the country’s oldest and most prestigious university (Makerere 
University), collaborates with University of Cambridge, the 
London School of Hygiene & Tropical Medicine and other 
partners, and is currently funded through the African Academy 
of Sciences’ DELTAS Africa Initiative1,2. MUII aims to provide 
opportunities to bright young Ugandans to engage in Africa-led 
world-class research in I&I to provide solutions for Africa’s 
health challenges, and to contribute to improving global 
health. The current COVID-19 global crisis underscores the 
need for local expertise and infrastructure to support national 
responses to global health challenges within the local context.
MUII supports graduate training (master’s and doctoral students) 
and early career scientists (post-doctoral and group leaders) 
in I&I disciplines. In addition, MUII provides placements 
for undergraduate and new-graduate interns, including proactive 
support for individuals with disability, to develop interest and 
participate in biomedical research.
Unlike recent large-capacity building programmes that have 
focused on increasing the numbers and quality of medical 
graduates to support health care in resource-limited settings3,4, 
MUII supports development of local research scientists to 
harness cutting edge tools of immunology, molecular biology, 
genetics and bioinformatics to address the health challenges 
of tropical Africa1,2. Although PhD training has increased 
in the last decade through various collaborative programmes5, 
there is limited experience and data on growth of academic 
careers from PhD graduates to independent scientists and leaders 
in science, policy and practice. This gap is emphasised by the 
scarcity of post-doctoral and research fellow positions in the 
establishment of several academic institutions in Uganda and 
the sub-Saharan region. We therefore found it necessary to sys-
tematically investigate and document the drivers of the suc-
cess, the challenges and the key lessons from MUII that might 
be useful to other research capacity building programmes in 
Uganda and similar resource-limited settings, to further bridge 
the gap between doctoral degrees and academic research 
leadership, building public utility of local scientists to lead, 
inform and solve local problems within the global context.
Methods
Programme description
MUII supports a centre of excellence in I&I research and train-
ing, with a secretariat based at UVRI. The secretariat com-
prises the Director, Centre Manager, finance, administration, 
procurement, monitoring and evaluation, and communication 
teams which work in close collaboration with UVRI govern-
ment staff. In addition, MUII has employed scientific staff in 
areas requiring intensive support and development (initially a 
senior, expatriate immunologist; subsequently a more junior 
Ugandan immunologist (recently graduated from an Ameri-
can university); both at first full-time, later part-time. These 
supported initiation of core training in immunology, and sub-
sequently contributed to development of Makerere’s master’s 
degree in immunology and clinical microbiology, and the devel-
opment of a new department of Immunology and Molecular 
Biology, chaired by a MUII post-doctoral alumnus. Similarly, 
MUII has supported a lead scientist in bioinformatics, first as a 
post-doctoral fellow, subsequently as a part-time staff scientist.
MUII functions through core implementation teams called Impis 
(from the Zulu word for a band of warriors) which provide sup-
port for the fellows’ projects. The Impis include Immunol-
ogy, Bioinformatics, Fellowships, Mentorship, Monitoring and 
Evaluation, Internships and Diversity, as well as Community 
Engagement1,2. In addition to fellowships, MUII provides oppor-
tunities for endeavour awards to allow innovative interventions 
and visiting scientists awards to allow fellows to invite or 
visit international experts in specific fields of interest to build 
research expertise. An executive committee chaired by the Direc-
tor, with representation from each category of trainees (master’s, 
PhD and post-doctoral) and from each Impi, manages the imple-
mentation of the programme, with oversight from a steering 
committee. The programme has a Scientific Advisory Board 
(SAB) consisting of local and international experts in I&I 
who help to review all programme activities. A SAB mem-
ber usually chairs fellowship selection committees; and SAB 
members attend the Annual General Meeting, participating 
in review of fellows’ progress, programme goals, activities, 
outputs and outcomes (Figure 1).
Evaluation design and participants
We reviewed programme monitoring and evaluation data, includ-
ing annual reports (2008–2019), for quantitative data on number 
of trainees and outputs including publications and research 
grants. Additionally, in a cross-sectional study, qualitative evalu-
ation was conducted in March and April 2019 by F.Z., a social 
scientist at the medical research council (with MSc in Geron-
tology) independent of the MUII programme. A representative 
sample of 27 trainees (out of 50 then available), and two centre 
staff was purposefully selected. The purposive representative 
sample considered representation of five categories of fellows: 
Masters, PhD, post-doctoral and group-leader fellows, and hon-
orary fellows (not directly funded by MUII, but registered under 
MUII, participating in fellows’ meetings and training activi-
ties, and sometimes receiving small travel or equipment grants). 
The interviewer introduced herself to all interviewees on email, 
highlighted the purpose of the interview and made suit-
able appointments. All participants contacted accepted to par-
ticipate in face-to-face interviews during working hours. The 
interview was attended by the interviewer, interviewee and 
two media staff to audio and video record. Skype interviews 
were conducted with participants unavailable for face-to-face 
interaction. Each interview lasted at least 45 minutes.
Qualitative data collection
In-depth interviews (IDI) were conducted with the fellows and 
key informant interviews (KII) with staff, by using a pre-tested 
topic guide (see Extended data) to explore experiences from the 
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MUII programme over the last 10 years. The guide was designed 
to obtain insights into best practices, challenges, impact, and sus-
tainability of the impact beyond the programme, and included 
questions on new leadership roles and mentorship experience 
that fellows have been involved in after participating in the 
MUII programme.
Qualitative data management and analysis
Qualitative interviews and Skype calls were audio-recorded 
and later transcribed verbatim. These data were underpinned 
on content analysis, coded by F.Z., and analysed thematically 
using a framework that was informed by the study objectives 
and preliminary findings, according to pre-determined themes 
of achievements, challenges, lessons learned and recommen-
dations for improvement. The framework was for coding the 
study data with constant comparison across the team to ensure 
consistency. The coding of data was managed using NVivo 12.
Ethical review and consent
The protocol for the qualitative evaluation was reviewed by 
the Research Ethics Committee of the Uganda Virus Research 
Institute, which gave a waiver of written consent and approval to 
publish these routine program data (REF GC/127/19/03/699). 
Participants gave verbal consent to participation in the interviews 
and the use of the material from the interviews, including quotes, 
in this paper. Permission was sought from participants whose 
quotations appear in the paper.
Results
Achievements
MUII’s principal achievements comprise a) the successes 
and career progression of trainees, b) growth in Infection and 
Immunity (I&I) research and training capacity at MUII partner 
institutions in Uganda, and c) establishment of sustainable 
international collaborations for young Ugandan scientists.
Figure 1. MUII Internal and External Scientific and Advisory Review Structures
Advice and review is, and will be, provided by the Scientific Advisory Board (SAB) and by additional reviewers solicited among implementation 
colleagues (such as Ministries of Health, industry, non-governmental organisations) and expert colleagues from partner institutions (LSHTM, 
Cambridge, and collaborators. The large red arrow represents planning and progression of the programme as a whole; blue arrows represent 
recruitment and follow up of fellows and alumni. Numbers below explain those in the figure.
Advice on MUII3 programme strategy
1. The SAB participation in planning for MUII3 through 2019 and 2020 AGM and SAB meetings. Additional input from policy-makers and other 
potential “end-users” of research has been initiated, and will continue during the planning and execution of MUII3
2. The SAB review reports and progress at each future MUII3 AGM and guiding further direction
Advice on selection and progress of fellows
3. Preliminary applications long-listed by Executive and Steering Committee members
4. Expert review for each full application, usually solicited from expert collaborators beyond the SAB
5. Interview committees include SAB members and other reviewers, based on required expertise.
6. Fellows’ progress reviewed at AGMs by SAB members
7. High calibre external examiners and “opponents” for examinations
Advice for MUII’s emerging research leaders
8. Peer review and critical review by senior MUII scientists; independent expert review from scientists who are highly experienced in 
grantsmanship at LSHTM and Cambridge.
9. SAB members and other international collaborators provided mentorship for MUII fellows.
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Successes and career progression of trainees. Between January 
2008 and December 2019, MUII supported 68 fellowships 
including 23 master’s fellows, 27 PhD fellows, 15 post-doctoral 
fellows and three group leaders in I&I research. Of these, 
53 were directly funded by MUII, while 15 were honorary 
fellows (Table 1). By December 2019 these fellows, since 
joining MUII, had published over 300 peer-reviewed publications 
and received over 20 million Pound Sterling worth of additional 
funds for research (Figure 2). These were all desired outputs of 
the programme demonstrating the achievement of the goal, “...to 
allow the Fellows to develop into independently funded research 
leaders” (EMEL028, M, KII, Centre Staff). Other members 
of staff commented that seeing alumni ‘take off’ and become 
independent was a clear mark of success.
Many MUII alumni have taken on academic leadership roles 
as Principal Investigators, Heads of Departments, Deans of 
Schools, supervisors of graduate students, and mentors of other 
emerging scientists. MUII also supported over 1000 internships 
at UVRI and exposed over 5000 high school students to 
scientific research through “Open Days” at UVRI.
Growth in I&I research at MUII partner institutions in 
Uganda. Before MUII was launched, there were few facilities 
for immunology research at Makerere University. Starting with 
a small immunology laboratory under the Department of Micro-
biology, MUII contributed to human, technical and physical 
infrastructural development in I&I capacity. This is evidenced 
by new Masters’ and doctoral training programmes in Immunol-
ogy and Clinical Microbiology and in Genomics and Bioinfor-
matics (with increasing numbers of applicants), that have been 
developed with MUII alumni as heads of departments, super-
visors and investigators in multi-disciplinary Infection and 
Immunity research (Table 2).
“Seeing these young Ugandans that have an interest in immu-
nology, seeing that interest develop, bud and flower into a 
full-blown passion for immunology and seeing them start 
Figure 2. Research outputs by MUII fellows between January 2008 and December 2019: A shows peer-reviewed publications and B) shows 
amount of research funding received. 
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Table 1. Infection and Immunity research trainees between January 2008 and 
December 2019.
MUII-funded Honorary Total
Female gender 
N (%)
Group Leaders 3 0 3 2 (67)
Post-docs 15 0 15 7 (47)
Doctoral students (PhD) 17 10 27 14 (52)
MSc students 18 5 23 11 (48)
Overall 53 15 68 34 (50)
Table 2. Growth in Infection and Immunity (I&I) Research at partner institutions Uganda Virus Research Institute and Makerere 
University.
MUII contribution Makerere University Uganda Virus Research Institute
Research support
Infrastructural 
development
Laboratories within College of Health Sciences and 
College of Veterinary Medicine, Animal Resources 
and Biosecurity Computer laboratory, College of 
Natural Sciences 
Training building with offices, meeting rooms and 
conferencing facilities and training laboratory 
IT equipment, software 
Financial systems equipment, software 
Support staff salaries and training
Laboratory capacity Technician Support and equipment to translational lab 
at Infectious Diseases Institute 
Technology transfer by fellows training abroad
Training Laboratory management 
Laboratory equipment 
Technology transfer by fellows training abroad
Infection and immunity 
training programmes
Developed short course: Immunology in the tropics 
Contributed to start of MSc Immunology and 
Molecular biology 
Video-conferenced expert seminars 
Supported one immunologist 
Support to MSc and PhD in bioinformatics
Strengthened bioinformatics core with masters, 
doctoral and post-doctoral trainees 
Supported one immunologist 
Supported one molecular biologist/bioinformatician
Student supervision MUII trainees (MSc &PhD) were supervised by 
Makerere University faculty and collaborators 
MUII alumni continue to supervised MSc &PhD 
students
MUII trainees (MSc &PhD) were supervised by 
UVRI faculty and collaborators 
Supported one statistician to provide fellows’ 
statistical guidance
Citizenship
Research leadership MUII alumni are now heads of departments, Deans, 
and leaders of professional association boards
MUII alumni are now key investigators and 
collaborators on institutional and collaborative 
projects
Developing collaborations 
& networks
All PhD, post-doctoral and group-leader fellows have 
travel support for collaboration 
Competitive Travel awards for programme staff and 
trainees 
Symposia and seminars
All PhD, post-doctoral and group-leader fellows 
have travel support for collaboration 
Competitive Travel awards for programme staff and 
trainees
Engagement with 
research participants & 
policy makers
All fellows receive funds for engagement All fellows receive funds for engagement 
Open Days hosted at UVRI
Programme organisation
Support to existing schedules of supervisors’ and 
doctoral meetings in line with directorate of research 
and graduate training 
Support trainees to adhere to institutional research 
regulatory processes
Administrative structure (secretariat) 
Executive Committee is representation of all the 
cadres, Masters, post-docs, PhDs 
Regular progress review meetings 
Monitoring & Evaluation 
Overarching Scientific Advisory Board of 
International experts in I&I
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thinking about their research in immunological terms and to 
start to win grants in immunology! That for me is success” 
(EMEL028, M, KII, Centre Staff)
Sustainable training and research collaborations. Through 
MUII, fellows created and consolidated collaborations and net-
works with over 40 institutions globally. Illustrative examples 
are listed in Table 3. These institutions have supported train-
ing in fields such as genetics, antimicrobial resistance, systems 
biology, bioinformatics, metagenomics, molecular and 
cell biology, vaccine development, and biomarker research 
(Table 3): fields in which world class expertise was not avail-
able in Uganda. In addition, these collaborations have helped to 
position fellows to achieve recognition internationally:
“…by linking me to Professors in the United Kingdom, it has 
really expanded my horizon because with them we have been 
able to compete at a bigger stage…Right now my light is shin-
ing because of this bigger stage that the collaboration has 
enabled me to get into. So it has really been very instrumental.” 
(EMEL015, M, IDI, Group Leader).
Challenges
However, interviewees reported several important challenges 
encountered.
Procurement. Delay in procurement of biological research sup-
plies was reported as a critical challenge. Most government 
procurement systems did not have provision for direct orders 
from international suppliers of reagents specifically used in 
published immunology protocols, without the bureaucracy of 
local agents. This was a bottleneck to timely implementation 
of research and many fellows relied on international laboratory 
placements to complete their work. One fellow commented: 
“I spent most of my time in the lab overseas to avoid delays 
because that is where I could get my supplies continuously deliv-
ered almost immediately from the manufacturing company.” 
(EMEL004, F, IDI, Group Leader). Others mentioned the need 
Table 3. An illustrative sample of local and international collaborations with MUII between January 2008 and December 2019.
Collaborating institution (name and country) Area of focus Roles/contribution to MUII trainees
Uganda Virus Research Institute, Uganda Laboratory skills MUII programme host, statistics and 
bioinformatics core
Makerere University College of Heath Sciences, 
Uganda
Immunology, Bio-informatics, clinical 
care, patient cohorts
Masters and doctoral Programmes
Makerere University College of Natural Sciences, 
Uganda
Mathematical modelling Trainees, mentors and dry lab space
Makerere University College of Veterinary Medicine, 
Animal Resources and Bio-Security, Uganda
Laboratory strengthening Immunology Trainees, mentors and wet lab space
Rakai Health Sciences Project, Uganda HIV pathogenesis and phylogenetics Community cohorts and wet labs
Cambridge University and Cambridge Africa 
programme, UK
Metagenomics Genetics of pre-
eclampsia
HLA typing, collaborative grant 
applications Training seminars
London School of Hygiene and Tropical Medicine, 
UK
Infection and Immunity Mentors, statistics core and Scientific 
advisory board membership
Gladstone Institute of Vaccine Immunology, San 
Francisco, USA
HIV pathogenesis Laboratory skills training and mentorship
The Vaccine and Gene Therapy Institute, Florida, 
USA
Systems biology Laboratory skills training, workshop 
facilitation and mentorship
Case Western Reserve University, Ohio, USA Systems biology Laboratory skills training, workshop 
facilitation and mentorship
The Jenner Institute, Oxford, UK Tuberculosis Vaccinology Laboratory skills training and mentorship
Addenbrooke’s Hospital, Cambridge, UK Genetics of pre-eclampsia Laboratory skills training and mentorship
University of St. Andrews, UK Antimicrobial resistance Laboratory skills training and mentorship
University of Edinburgh, UK Bioinformatics Training and mentorship
PANGEA Network Bioinformatics Training and mentorship
Imperial College London, UK Bioinformatics Training and mentorship
Sanger Institute, UK Metagenomics Training and mentorship
Leiden University Medical Center, Netherlands Parasite immunology and vaccines Laboratory skills training and mentorship
University of Geneva Human Protein Lab, 
Switzerland
Plasma staging biomarkers Laboratory skills training and mentorship
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to place orders directly with manufacturers to avoid local agents 
and procurement delays.
Nevertheless, the procurement teams at UVRI and Makerere 
worked together to understand the issues affecting the research-
ers and did their best within the allowable clauses and limitations 
in policies for procurement of research reagents and equipment.
Time management. A common challenge for fellows was to 
meet deadlines, and many mentioned that they had to bal-
ance research with their clinical and teaching responsi-
bilities: “One still has to perform their roles as a clinician, 
teacher, researcher, Head of Department, wife, mother, etc.” 
(EMEL001, F, IDI, post-doc). Time pressure increased as fellows 
advanced in their research career.
Limited pool of clinical immunology and bioinformatics 
experts. Some fields had very limited local capacity for applica-
tion of immunology and bioinformatics tools to address chal-
lenging threats: for example, the field of maternal health for the 
challenge of pre-eclampsia. MUII responded to this challenge 
through the support of international collaborators (Table 3). 
Some of these collaborative efforts have resulted in lasting 
collaborations between fellows and supervisors, for example:
“The collaboration with Cambridge started with a PhD stu-
dent and her mentor but now lots of other people involved in 
the health arena from Cambridge are working with her depart-
ment. That is the ideal way we would like to see collaborations 
grow.” (EMEL029, F, KII, Centre Staff).
Uncertain sustainability of active research programmes beyond 
MUII. Maintaining active research beyond their MUII fund-
ing was a challenge for fellows, with the prospect of attract-
ing funding appearing quite daunting: “I need real significant 
funding which can maintain a group or team of six people for 
three years. I also need support in terms of someone comment-
ing on the proposal or application and being connected to 
people of similar interests.” (EMEL009, M, IDI, post-doc).
However, many fellows appreciated that this challenge was to be 
expected and competitive resource mobilisation is part of being 
a research scientist. To address this challenge, MUII organ-
ised skills-building meetings for fellows including grant writing 
and peer-review to increase the competitiveness of applica-
tions. In addition, MUII supports a mentorship programme 
where fellows can be linked to experts in their field.
Lessons learned regarding key contributors to success
Interviewees shared key lessons learned in capacity building for 
research in resource-limited settings.
Programme administration and organisation. Good operational 
management was key to success of the training and research 
programme (Figure 1 and Table 2). The distribution of roles 
to improve efficiency and the monitoring and evaluation func-
tions helped the fellows to adhere to research regulations and 
programme timelines for master’s and doctoral students. Many 
of the fellows were grateful for the support they had received to 
enable them to graduate.
“MUII has had 100% success of [Masters] graduation on 
time. The programme pays attention to the Fellows. I think it 
has been excellent in terms of mentorship of the Fellows...” 
(EMEL005, M, IDI, master’s).
Multi-disciplinary collaboration within Uganda between 
leading academic and research institutions. MUII showed 
that it was feasible to develop and sustain collaborations 
between UVRI and the Makerere Colleges of Health Sci-
ences; Veterinary Medicine, Animal Resources and Biosecurity; 
Natural Sciences; and Computing and Information Sciences 
(Table 3). This collaborative infrastructure was appreciated 
by fellows as a strength:
“…I applied [for the Group Leader Position] because I thought 
it would really give this cross multi disciplinarity, not just 
being at Makerere University, but also interacting with other 
research institutions in Uganda. UVRI is a premiere research 
institution in this country. So I thought it would be an oppor-
tunity for me to liaise with other scientists…” (EMEL015, 
M, IDI, Group Leader).
Procurement of research reagents and equipment. Public aca-
demic and research institutions need to be supported to foster 
active framework agreements with international manufacturers of 
biological research reagents to minimise time delays created by 
looking for local agents who do not routinely import items that 
are specific to biological laboratory experiments and innovations.
Mentorship. Supporting young researchers to progress through 
MSc, PhD and post-doc programmes and subsequently to 
develop as group leaders to mentor other upcoming scientists 
and maintain the pipeline has been greatly valued.
“During the ten-year period, there were opportunities for 
MUII graduates at any level to apply (competing with other 
non-MUII applicants) for available MUII opportunities at the 
next level of career development. ‘I was privileged to have a 
very good supervisor and mentor who gave me time, gave my 
applications time and gave my research ideas time. So that I 
attribute to mentorship.” (EMEL001, F, IDI, post-doc).
Sustainability of I&I research. Most fellows and graduates 
of the MUII programme have been able to win career devel-
opment and research grants to sustain their research groups. 
Fellows, however, mentioned their need for more technical 
support to respond to funding opportunities as well as addi-
tional training in community engagement, leadership, and data 
management.
“I think we’ve been a pretty good example across the whole 
DELTAS [funding programme] network in getting out early 
PhD Fellows and they are in a position of getting their own 
research grants, they are heads of departments, deans of fac-
ulties and they are running their own profile research. I think 
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that is where the sustainability comes in.” (EMEL028, M, KII, 
Centre Staff).
Similarly, the MUII alumni that have grown professionally to 
take academic and research leadership positions are nurtur-
ing a culture that fosters high quality research in I&I research 
and are already mentoring other upcoming scientists.
“We have had a PhD funded fellow who is now working as 
Dean at the Vet School. We have a Group Leader who is the 
Dean of the Medical School. We have another Group Leader 
who is the head of the Obs and Gyn Department. So I think 
through them and other MUII alumni in other influential areas 
at Makerere University would make MUII and other research 
collaborations more sustainable.” (EMEL029, F, KII, Centre 
Staff).
“…I have six PhD students that I supervise and mentor but 
in addition to that I mentor many other gynaecologists, even 
students outside my department…I mentor over 20 [students] 
because every time people come to consult me on different 
things.” (EMEL018, F, IDI, Group Leader).
Discussion
The MUII capacity-building programme in I&I has demon-
strated ten years of high quality training in emerging tools 
of immunology and bioinformatics to answer locally gener-
ated questions to address gaps in knowledge and practice in 
the dominating infections of HIV, tuberculosis, malaria and its 
complications, helminths and emerging viruses, as well as the 
rising burden of non-communicable diseases including asthma, 
diabetes, hypertension and pre-eclampsia6–32. Through the 
spectrum of fellowships provided, from the most junior of under-
graduate interns to master’s, doctoral, post-doctoral and group-
leader awards, MUII has provided mentored research training 
opportunities to foster growth of academic research careers. 
With the engagement of scientific and non-scientific community, 
MUII scientists disseminated their science, its relevance in 
the local context and exposed it to over 5000 high school 
students (tomorrow’s scientists). The impact has been demon-
strated by the programme monitoring and evaluation indicators 
that include, among others, peer-reviewed publications, addi-
tional funding for research and capacity building obtained by 
trainees, emergence of multi-disciplinary research groups, 
increasing applicants to the new MUII-supported masters’ and 
doctoral programmes in immunology and bioinformatics, and 
number of active local and international collaborations.
Unlike capacity-building initiatives that have focused on increas-
ing the number of medical graduates for health care3,4 and 
doctoral training in various fields5,33, MUII has focused on 
developing experts in I&I - a major gap that slackens local bio-
medical responses to emerging infections in Africa. In addition, 
MUII has embraced the challenge of technology trans-
fer of new immunology and bioinformatics techniques 
with the aim that MUII trainees will be empowered to lead novel 
initiatives like developing vaccine or therapeutic targets for 
emerging diseases. In a modest way, MUII tried to mimic what 
developing an academic research career would entail in high-
income settings, where a developing research group requires 
fellowship schemes to kick-start scientists, PhD students and 
post-docs to be part of novel ideas and publications, techni-
cians to support high-throughput equipment, dry laboratory 
scientists for genomic analyses and mathematical modelling2. 
We recommend monitoring of equipment booking schedules 
to use wet laboratory equipment for immunology and molecu-
lar biology assays, abstracts presented at relevant local and 
international meetings, meetings held by our scientists with 
community, policymakers and other relevant stakeholders to 
demonstrate productivity and utility of the scientists. These 
are all critical for the next level of development of science in 
Africa. Improved management strategies are needed to tackle the 
epidemiological change facing Africa due to urbanisation and 
changes in lifestyle like the emerging burden of non-communicable 
diseases (NCDs) in Africa2. Appropriate diagnostics, treatment 
and vaccines are needed in the face of unprecedented emerging 
pandemics, such as the current COVID-19 crisis. Locally 
generated evidence is critical to local management of such 
global pandemics; with examples of fast-tracked clinical trial 
data emerging from China and USA34,35 and the reliance of 
countries on their leading scientists36 to inform national and global 
interventions. There is need for clinical trials within the local and 
cultural context of communities and health system. For example, 
it is not obvious that host responses to hydroxychloroquine and 
azithromycin as COVID-19 trial therapies in America would 
be similar to those in sub-Saharan Africa where both drugs 
have been used commonly for endemic malaria and atypical 
pneumonias, or that vaccines developed in high-income 
settings will be equally effective in Africa.
The MUII experience is unprecedented because of the previ-
ous absence of local advanced training programmes (MSc and 
doctoral level) in immunology and bioinformatics to advance 
locally trained scientists in I&I research. Therefore, the lessons 
learned over the decade of implementation of the programme, 
presented here, are noteworthy to inform ongoing and future 
capacity building programmes on the African continent.
MUII had a dedicated secretariat to support programme com-
munications, tracking, and evaluation. In addition, MUII sup-
ported two immunologists to be part of the new department 
of Immunology and Molecular Biology that is chaired by a 
former MUII post-doc. Similar input was previously illus-
trated by an ongoing capacity building programme for cancer 
research that protected support staff time of approximately 0.25 
to 0.5 full-time equivalents contributed to the success of the 
programme37. The MUII secretariat also organised regular meet-
ings which made it easy for people to be accountable not only 
for their time but also to their set goals. MUII also offered train-
ing in research methods, data analysis, use of data analysis 
software packages, grant writing, report writing, presentation 
skills, among others. During the regular programme capac-
ity building meetings, fellows would critique each other’s work, 
which greatly improved the quality of proposals and presenta-
tions. Fellows also had opportunities to participate in different 
workshops and conferences. MUII fellows were prepared 
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to become better mentors, and many of them acquired peer 
mentees, as previously noted that peer mentorship greatly 
supported in-country capacity building initiatives37. At the 
regular progress meetings fellows discussed bottlenecks in their 
progress such as delayed procurement of specific reagents and 
equipment that required direct importation from manufacturers 
abroad. Both MUII institutions (UVRI and Makerere) still 
need support to develop and implement efficient policies that 
reduce the turn-around time for research reagents and equipment 
orders, many of which are expensive sole supplier items because 
of previously optimised protocols and equipment38.
MUII programme increased trainees’ networking opportunities 
through the large pool of multi-disciplinary scientists and 
through several collaborations established as well as the visiting 
scientist awards where fellows also had opportunities to invite 
expert scientists to support training and research locally. 
For example, as part of a visiting award, the translational 
immunology group led by Damalie Nakanjako (Physician) 
invited an expert in multicolour flowcytometry (Glenda Canderan 
from the Department of Pathology at Case Western Reserve 
University, USA) to support the team through their large flow-
cytometry panels using the 20-color LSRII flowcytometer at 
UVRI campus. Subsequently the team published important 
results that demonstrated persistent innate immune dysfunction 
(NK cells, monocytes and Innate lymphoid cells) despite 
long-term antiretroviral therapy23–25. Similarly, maternal health 
group, led by Annettee Nakimuli (Obstetrician and Gynaecology), 
through Ashley Moffet and Corina Alberg provided several 
opportunities for Uganda’s junior scientists to network and 
collaborate with experts in the field of KIR genes and their role 
in pre-eclampsia which is the leading cause of poor maternal 
and fetal outcomes in Uganda26,39. Subsequently two more 
PhD students are being trained in this field on the programme. 
In addition, Makerere University graduate trainees (MSc and 
doctoral) and staff in Immunology and Bioinformatics attend 
regular remote seminars provided by Cambridge University using 
the WebEx (Cisco WebEx, Milpitas, CA).
Each of MUII’s PhD and post-doctoral Fellows had the oppor-
tunity to travel as they had to have an international collaborator 
as well as local collaborators. That approach multiplied the 
collaborations by the number of fellows. In a survey of a 
cancer research capacity building programme, training doctoral 
students and fellows, only 3/38 (7%) had adequate opportuni-
ties to network with other researchers37. Our involvement of 
world-class experts in the fields of interest helped to mitigate 
the previously noted challenge of limited experts to mentor 
emerging scientists in Uganda40,41. Collaborators/co-supervisors 
and co-mentors were key elements in the programme because 
of the limited critical mass of mid-and-advanced career 
scientists in the country. In the past, many of Uganda’s 
experts were scattered globally due to cultural, geopolitical 
and socio-economic drivers of brain drain37,38,41. Fellows high-
lighted that MUII provided them a lot of exposure that opened 
several opportunities to pursue careers in research. The multi-
disciplinary nature of the collaborations established by MUII 
has birthed long-term bonds with the participating institu-
tions of LSHTM, Cambridge University and the Sanger 
Institute, among others; which will continue to be utilised 
by students and faculty beyond the MUII funding.
Conclusion
MUII has demonstrated a decade of mentored academic pro-
ductivity in I&I research. Its sustainability is evidenced by the 
continuing mentorship, research groups, training programmes, 
resource mobilisation and global collaborations that have emerged 
to contribute to solutions to Africa’s health care problems. More 
skills and commitment remain necessary for trainees in develop-
ing countries to compete favourably for international research 
funding to build and sustain a critical mass of I&I scientists, 
to respond to current and emerging health problems.
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